Early use of granulocyte colony stimulating factor improves survival in a rabbit model of chronic myocardial ischemia

Journal of Cardiology

Volumn 61, Issue 1, 2013, Pages 87-94

  Zhao, Qingbin ^a   Sun, Chaofeng ^a   Xu, Xin ^b   Zhou, Juan ^c   Wu, Yue ^a   Tian, Yuling ^a   Ma, Aiqun ^a   Liu, Zhiquan ^a  

^a THE FIRST AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

^b THE SECOND AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

^c MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

Apoptosis; G CSF; Myocardial ischemia; Neovascularization

Indexed keywords

DEOXYURIDINE TRIPHOSPHATE PYROPHOSPHATASE; GRANULOCYTE COLONY STIMULATING FACTOR; SODIUM; VASCULOTROPIN; VON WILLEBRAND FACTOR;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CD34 SELECTION; CELL HOMING; CONTROLLED STUDY; HEART MUSCLE ISCHEMIA; IMMUNOHISTOCHEMISTRY; ISCHEMIA; LIGATION; MALE; NICK END LABELING; NONHUMAN; POSTOPERATIVE PERIOD; PROTEIN EXPRESSION; RABBIT; STEM CELL MOBILIZATION; SURVIVAL; UPREGULATION;

ANIMALS; ANTIGENS, CD34; APOPTOSIS; CHRONIC DISEASE; CORONARY VESSELS; DISEASE MODELS, ANIMAL; GRANULOCYTE COLONY-STIMULATING FACTOR; INJECTIONS, SUBCUTANEOUS; MALE; MYOCARDIAL ISCHEMIA; MYOCARDIUM; NEOVASCULARIZATION, PHYSIOLOGIC; RABBITS; RNA, MESSENGER; STIMULATION, CHEMICAL; SURVIVAL RATE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84872395398     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2012.09.003     Document Type: Article

References (41)

1. Shinsato T., Miyata M., Kubozono T., Ikeda Y., Fujita S., Kuwahata S., Akasaki Y., Hamasaki S., Fujiwara H., Tei C. Waon therapy mobilizes CD34+ cells and improves peripheral arterial disease. J Cardiol 2010, 56:361-366.
2. Miyata S., Takemura G., Kawase Y., Li Y., Okada H., Maruyama R., Ushikoshi H., Esaki M., Kanamori H., Li L., Misao Y., Tezuka A., Toyo-Oka T., Minatoguchi S., Fujiwara T., et al. Autophagic cardiomyocyte death in cardiomyopathic hamsters and its prevention by granulocyte colony-stimulating factor. Am J Pathol 2006, 168:386-397.
3. Orlic D., Kajstura J., Chimenti S., Jakoniuk I., Anderson S.M., Li B., Pickel J., McKay R., Nadal-Ginard B., Bodine D.M., Leri A., Anversa P. Bone marrow cells regenerate infarcted myocardium. Nature 2001, 410:701-705.
4. Wagers A.J., Sherwood R.I., Christensen J.L., Weissman I.L. Little evidence for developmental plasticity of adult hematopoietic stem cells. Science 2002, 297:2256-2259.
5. Taylor D.A., Hruban R., Rodriguez E.R., Goldschmidt-Clermont P.J. Cardiac chimerism as a mechanism for self-repair: does it happen and if so to what degree?. Circulation 2002, 106:2-4.
6. Hamamoto M., Tomita S., Nakatani T., Yutani C., Yamashiro S., Sueda T., Yagihara T., Kitamura S. Granulocyte-colony stimulating factor directly enhances proliferation of human troponin I-positive cells derived from idiopathic dilated cardiomyopathy through specific receptors. J Heart Lung Transplant 2004, 23:1430-1437.
7. Harada M., Qin Y., Takano H., Minamino T., Zou Y., Toko H., Ohtsuka M., Matsuura K., Sano M., Nishi J., Iwanaga K., Akazawa H., Kunieda T., Zhu W., Hasegawa H., et al. G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes. Nat Med 2005, 11:305-311.
8. Ueda K., Takano H., Hasegawa H., Niitsuma Y., Qin Y., Ohtsuka M., Komuro I. Granulocyte colony stimulating factor directly inhibits myocardial ischemia-reperfusion injury through Akt-endothelial NO synthase pathway. Arterioscler Thromb Vasc Biol 2006, 26:e108-e113.
9. Bussolino F., Wang J.M., Defilippi P., Turrini F., Sanavio F., Edgell C.J., Aglietta M., Arese P., Mantovani A. Granulocyte- and granulocyte-macrophage-colony-stimulating factors induce human endothelial cells to migrate and proliferate. Nature 1989, 337:471-473.
10. Bussolino F., Ziche M., Wang J.M., Alessi D., Morbidelli L., Cremona O., Bosia A., Marchisio P.C., Mantovani A. In vitro and in vivo activation of endothelial cells by colony-stimulating factors. J Clin Invest 1991, 87:986-995.
11. Pelletier L., Regnard J., Fellmann D., Charbord P. An in vitro model for the study of human bone marrow angiogenesis: role of hematopoietic cytokines. Lab Invest 2000, 80:501-511.
12. Chen X., Kelemen S.E., Autieri M.V. AIF-1 expression modulates proliferation of human vascular smooth muscle cells by autocrine expression of G-CSF. Arterioscler Thromb Vasc Biol 2004, 24:1217-1222.
13. Lee M., Aoki M., Kondo T., Kobayashi K., Okumura K., Komori K., Murohara T. Therapeutic angiogenesis with intramuscular injection of low-dose recombinant granulocyte-colony stimulating factor. Arterioscler Thromb Vasc Biol 2005, 25:2535-2541.
14. Dawn B., Guo Y., Rezazadeh A., Huang Y., Stein A.B., Hunt G., Tiwari S., Varma J., Gu Y., Prabhu S.D., Kajstura J., Anversa P., IIdstad S.T., Bolli R. Postinfarct cytokine therapy regenerates cardiac tissue and improves left ventricular function. Circ Res 2006, 98:1098-1105.
15. Sugano Y., Anzai T., Yoshikawa T., Maekawa Y., Kohno T., Mahara K., Naito K., Ogawa S. Granulocyte colony-stimulating factor attenuates early ventricular expansion after experimental myocardial infarction. Cardiovasc Res 2005, 65:446-456.
16. Minatoguchi S., Takemura G., Chen X.H., Wang N., Uno Y., Koda M., Arai M., Misao Y., Lu C., Suzuki K., Goto K., Komada A., Takahashi T., Kosai K., Fujiwara T., et al. Acceleration of the healing process and myocardial regeneration may be important as a mechanism of improvement of cardiac function and remodeling by postinfarction granulocyte colony-stimulating factor treatment. Circulation 2004, 109:2572-2580.
17. Ohtsuka M., Takano H., Zou Y., Toko H., Akazawa H., Qin Y., Suzuki M., Hasegawa H., Nakaya H., Komuro I. Cytokine therapy prevents left ventricular remodeling and dysfunction after myocardial infarction through neovascularization. FASEB J 2004, 18:851-853.
18. Deindl E., Zaruba M.M., Brunner S., Huber B., Mehl U., Assmann G., Hoefer I.E., Mueller-Hoecker J., Franz W.M. G-CSF administration after myocardial infarction in mice attenuates late ischemic cardiomyopathy by enhanced arteriogenesis. FASEB J 2006, 20:956-958.
19. Kanellakis P., Slater N.J., Du X.J., Bobik A., Curtis D.J. Granulocyte colony stimulating factor and stem cell factor improve endogenous repair after myocardial infarction. Cardiovasc Res 2006, 70:117-125.
20. Hasegawa H., Takano H., Shiraishi H., Ueda K., Niitsuma Y., Tadokoro H., Komuro I. Intracoronary injection of granulocyte colony-stimulating factor ameliorates the progression of left ventricular remodeling after myocardial ischemia/reperfusion in rabbits. Circ J 2006, 70:942-944.
21. Sesti C., Hale S.L., Lutzko C., Kloner R.A. Granulocyte colony-stimulating factor and stem cell factor improve contractile reserve of the infarcted left ventricle independent of restoring muscle mass. J Am Coll Cardiol 2005, 46:1662-1669.
22. Kuhlmann M.T., Kirchhof P., Klocke R., Hasib L., Stypmann J., Fabritz L., Stelljes M., Tian W., Zwiener M., Mueller M., Kienast J., Breithardt G., Nikol S. G-CSF/SCF reduces inducible arrhythmias in the infarcted heart potentially via increased connexin43 expression and arteriogenesis. J Exp Med 2006, 203:87-97.
23. Saito Y., Kondo H., Hojo Y. Granzyme B as a novel factor involved in cardiovascular diseases. J Cardiol 2011, 57:141-147.
24. Roberts A.W. G-CSFa key regulator of neutrophil production, but that's not all!. Growth Factors 2005, 23:33-41.
25. Petit I., Szyper-Kravitz M., Nagler A., Lahav M., Peled A., Habler L., Ponomaryov T., Taichman R.S., Arenzana-Seisdedos F., Fujii N., Sandbank J., Zipori D., Lapidot T. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat Immunol 2002, 3:687-694.
26. Papayannopoulou T. Current mechanistic scenarios in hematopoietic stem/progenitor cell mobilization. Blood 2004, 103:1580-1585.
27. Wright D.E., Bowman E.P., Wagers A.J., Butcher E.C., Weissman I.L. Hematopoietic stem cells are uniquely selective in their migratory response to chemokines. J Exp Med 2002, 195:1145-1154.
28. Ceradini D.J., Kulkarni A.R., Callaghan M.J., Tepper O.M., Bastidas N., Kleinman M.E., Capla J.M., Galiano R.D., Levine J.P., Gurtner G.C. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 2004, 10:858-864.
29. Wynn R.F., Hart C.A., Corradi-Perini C., O'Neill L., Evans C.A., Wraith J.E., Fairbairn L.J., Bellantuono I. A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow. Blood 2004, 104:2643-2645.
30. Semerad C.L., Christopher M.J., Liu F., Short B., Simmons P.J., Winkler I., Levesque J.P., Chappel J., Ross F.P., Link D.C. G-CSF potently inhibits osteoblast activity and CXCL12 mRNA expression in the bone marrow. Blood 2005, 106:3020-3027.
31. Levesque J.P., Liu F., Simmons P.J., Betsuyaku T., Senior R.M., Pham C., Link D.C. Characterization of hematopoietic progenitor mobilization in protease-deficient mice. Blood 2004, 104:65-72.
32. Dlubek D., Drabczak-Skrzypek D., Lange A. Low CXCR4 membrane expression on CD34(+) cells characterizes cells mobilized to blood. Bone Marrow Transplant 2006, 37:19-23.
33. Kim H.K., De La Luz Sierra M., Williams C.K., Gulino A.V., Tosato G. G-CSF down-regulation of CXCR4 expression identified as a mechanism for mobilization of myeloid cells. Blood 2006, 108:812-820.
34. Schioppa T., Uranchimeg B., Saccani A., Biswas S.K., Doni A., Rapisarda A., Bernasconi S., Saccani S., Nebuloni M., Vago L., Mantovani A., Melillo G., Sica A. Regulation of the chemokine receptor CXCR4 by hypoxia. J Exp Med 2003, 198:1391-1402.
35. Abbott J.D., Huang Y., Liu D., Hickey R., Krause D.S., Giordano F.J. Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation 2004, 110:3300-3305.
36. Ohki Y., Heissig B., Sato Y., Akiyama H., Zhu Z., Hicklin D.J., Shimada K., Ogawa H., Daida H., Hattori K., Ohsaka A. Granulocyte colony-stimulating factor promotes neovascularization by releasing vascular endothelial growth factor from neutrophils. FASEB J 2005, 19:2005-2007.
37. Urbich C., Aicher A., Heeschen C., Dernbach E., Hofmann W.K., Zeiher A.M., Dimmeler S. Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. J Mol Cell Cardiol 2005, 39:733-742.
38. Iwanaga K., Takano H., Ohtsuka M., Hasegawa H., Zou Y., Qin Y., Odaka K., Hiroshima K., Tadokoro H., Komuro I. Effects of G-CSF on cardiac remodeling after acute myocardial infarction in swine. Biochem Biophys Res Commun 2004, 325:1353-1359.
39. Misao Y., Takemura G., Arai M., Ohno T., Onogi H., Takahashi T., Minatoguchi S., Fujiwara T., Fujiwara H. Importance of recruitment of bone marrow-derived CXCR4(+) cells in post-infarct cardiac repair mediated by G-CSF. Cardiovasc Res 2006, 71:455-465.
40. Kocher A.A., Schuster M.D., Szabolcs M.J., Takuma S., Burkhoff D., Wang J., Homma S., Edwards N.M., Itescu S. Neovascularization of ischemic myocardium by human bone marrow derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 2001, 7:430-436.
41. Orlic D., Kajstura J., Chimenti S., Limana F., Jakoniuk I., Quaini F., Nadal-Ginard B., Bodine D.M., Leri A., Anversa P. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci USA 2001, 98:10344-10349.